HHS awards $80.8M contract for advanced biotech R&D support to Tunnell Consulting Inc

Contract Overview

Contract Amount: $80,763,392 ($80.8M)

Contractor: Tunnell Consulting Inc

Awarding Agency: Department of Health and Human Services

Start Date: 2023-07-13

End Date: 2025-08-31

Contract Duration: 780 days

Daily Burn Rate: $103.5K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: R&D

Official Description: PROVIDE ADVANCE PROFESSIONAL SCIENTIFIC SUBJECT MATTER EXPERTISE (SMES) PROFESSIONAL SUPPORT SERVICES IN R&D/AR&D OF BIOTECHNOLOGY AND BIOPHARMACEUTICALS WITH AN ADVANCED UNDERSTANDING OF THE LICENSURES/APPROVAL OF PRODUCTS THROUGH THE FOOD A

Place of Performance

Location: BERWYN, CHESTER County, PENNSYLVANIA, 19312

State: Pennsylvania Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $80.8 million to TUNNELL CONSULTING INC for work described as: PROVIDE ADVANCE PROFESSIONAL SCIENTIFIC SUBJECT MATTER EXPERTISE (SMES) PROFESSIONAL SUPPORT SERVICES IN R&D/AR&D OF BIOTECHNOLOGY AND BIOPHARMACEUTICALS WITH AN ADVANCED UNDERSTANDING OF THE LICENSURES/APPROVAL OF PRODUCTS THROUGH THE FOOD A Key points: 1. Contract focuses on critical R&D and regulatory approval support for biotechnology and biopharmaceuticals. 2. High level of specialized expertise required, indicating a niche but vital service area. 3. Firm-fixed-price contract type suggests cost certainty for the government. 4. Performance period extends over two years, allowing for sustained support. 5. The contract is a delivery order under a larger contract vehicle. 6. Geographic focus on Pennsylvania for service delivery.

Value Assessment

Rating: good

The contract value of $80.8 million over approximately two years for specialized scientific subject matter expertise in biotechnology R&D and regulatory affairs appears reasonable given the niche and high-skill nature of the services. Benchmarking against similar contracts for advanced scientific consulting is challenging due to the specificity, but the firm-fixed-price structure provides a degree of cost control. The value reflects the complexity of navigating FDA licensures and approvals.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple qualified vendors had the opportunity to bid. This competitive process is expected to yield fair market pricing and a selection of the most capable offeror. The specific number of bidders is not provided, but the 'full and open' designation is a positive indicator of a robust competition.

Taxpayer Impact: Full and open competition generally benefits taxpayers by driving down prices through market forces and ensuring the government receives the best value from a wide pool of potential providers.

Public Impact

The primary beneficiaries are the Department of Health and Human Services (HHS) and potentially the public through the advancement of biotechnology and biopharmaceutical products. Services delivered include crucial scientific subject matter expertise for research, development, and regulatory approval processes. Geographic impact is centered in Pennsylvania, where the contractor is located. Workforce implications involve highly skilled scientific and consulting professionals.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for vendor lock-in if Tunnell Consulting becomes indispensable for specific regulatory pathways.
Reliance on a single delivery order for a significant portion of the contract value could concentrate risk.
The highly specialized nature of the expertise means a limited pool of replacement contractors.
Ensuring continuous knowledge transfer and documentation is crucial for long-term program continuity.

Positive Signals

Awarded through full and open competition, suggesting a competitive pricing environment.
Firm-fixed-price contract type provides budget predictability.
The contract supports critical public health initiatives in biotechnology and biopharmaceuticals.
The contractor's specialization aligns directly with the stated needs of the agency.
The contract duration allows for sustained, focused support on complex R&D and approval processes.

Sector Analysis

This contract falls within the professional, scientific, and technical services sector, specifically focusing on management and scientific consulting related to biotechnology and biopharmaceuticals. This is a high-value, knowledge-intensive area driven by innovation and stringent regulatory oversight. The market size for such specialized consulting is significant, supporting pharmaceutical companies, research institutions, and government agencies in navigating complex development and approval pathways, particularly with agencies like the FDA.

Small Business Impact

The data indicates this contract was awarded under full and open competition and does not specify any small business set-aside. Therefore, direct subcontracting opportunities for small businesses are not explicitly detailed within this award. However, the prime contractor, Tunnell Consulting Inc., may engage small businesses for specialized support services as part of their overall service delivery, depending on their internal subcontracting strategy.

Oversight & Accountability

Oversight for this contract would typically reside within the Office of Assistant Secretary for Preparedness and Response (ASPR) at HHS. Accountability measures are embedded in the firm-fixed-price contract terms, requiring delivery of specified services and expertise. Transparency is generally maintained through contract award databases and reporting requirements, though specific performance metrics and oversight activities are internal to the agency.

Related Government Programs

Biotechnology Research and Development Support
Pharmaceutical Regulatory Affairs Consulting
Advanced Scientific Subject Matter Expertise Services
Health and Human Services R&D Contracts
FDA Product Licensure and Approval Support

Risk Flags

Specialized Expertise Dependency
Regulatory Landscape Volatility
Knowledge Transfer and Continuity
Potential for Scope Creep in R&D

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $80.8 million to TUNNELL CONSULTING INC. PROVIDE ADVANCE PROFESSIONAL SCIENTIFIC SUBJECT MATTER EXPERTISE (SMES) PROFESSIONAL SUPPORT SERVICES IN R&D/AR&D OF BIOTECHNOLOGY AND BIOPHARMACEUTICALS WITH AN ADVANCED UNDERSTANDING OF THE LICENSURES/APPROVAL OF PRODUCTS THROUGH THE FOOD A

Who is the contractor on this award?

The obligated recipient is TUNNELL CONSULTING INC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).

What is the total obligated amount?

The obligated amount is $80.8 million.

What is the period of performance?

Start: 2023-07-13. End: 2025-08-31.

What is Tunnell Consulting Inc.'s track record with government contracts, particularly within HHS or related scientific fields?

Tunnell Consulting Inc. has a history of providing professional services, including management and scientific consulting. While specific details on all past government contracts require deeper database searches, their specialization in areas relevant to biotechnology and biopharmaceutical R&D suggests prior experience. Analyzing their past performance on similar contracts, especially those involving regulatory affairs or advanced scientific support for agencies like HHS or its components, would be crucial. This includes examining past performance evaluations, any contract disputes, and their success in meeting project milestones and deliverables on previous government engagements to assess their reliability and capability for this current $80.8 million award.

How does the $80.8 million contract value compare to similar specialized scientific consulting services for R&D and regulatory affairs?

Benchmarking the $80.8 million contract value requires comparing it against contracts for highly specialized scientific subject matter expertise (SME) in biotechnology and biopharmaceutical R&D and regulatory affairs. Given the advanced nature of the work, which includes understanding complex licensures and approvals through bodies like the FDA, this value appears substantial but potentially justified. Similar contracts often involve multi-year durations and require niche expertise that commands premium rates. Without specific comparable contract data, it's difficult to definitively state if it's high or low, but the firm-fixed-price structure suggests a defined scope and cost expectation. The value likely reflects the scarcity of specialized talent and the critical nature of ensuring product safety and efficacy.

What are the key performance indicators (KPIs) or metrics used to assess the success of this contract?

While specific KPIs are not publicly detailed for this contract, typical performance indicators for such specialized scientific consulting would likely include the successful delivery of expert analysis, timely completion of project milestones related to R&D phases, and effective support in navigating regulatory submission processes. For instance, metrics could track the quality and timeliness of scientific reports, the effectiveness of guidance provided on regulatory pathways, and the contractor's ability to anticipate and address potential challenges in product approval. The firm-fixed-price nature implies that meeting the defined scope of work and deliverables within the agreed budget and timeline are primary success factors. Adherence to scientific integrity and compliance with all relevant regulations would also be paramount.

What is the historical spending pattern for similar scientific advisory and R&D support services within HHS or ASPR?

Historical spending patterns for scientific advisory and R&D support services within HHS, particularly the Office of Assistant Secretary for Preparedness and Response (ASPR), can be significant, especially in areas related to public health emergencies, biodefense, and advanced medical countermeasures. ASPR, in particular, invests heavily in R&D to prepare for and respond to health threats. Analyzing past contract awards for similar services, including SME support, research grants, and development contracts in biotechnology and pharmaceuticals, would reveal trends. This contract's $80.8 million value should be viewed in the context of overall agency budgets allocated to R&D and preparedness, which can fluctuate based on national health priorities and emerging threats. Consistent or increasing investment in these areas suggests a sustained need for such expertise.

What are the potential risks associated with relying on Tunnell Consulting Inc. for critical R&D and regulatory approval support?

Potential risks associated with this contract include over-reliance on a single contractor for highly specialized knowledge, which could lead to knowledge gaps if the contract ends or the contractor underperforms. There's also a risk related to the dynamic nature of scientific research and regulatory landscapes; the contractor's expertise must remain current. If the firm-fixed-price contract doesn't adequately account for unforeseen scientific challenges or shifts in regulatory requirements, it could lead to scope creep or disputes. Furthermore, ensuring the contractor maintains the highest ethical standards and scientific integrity throughout the R&D and approval processes is critical. A failure in these areas could jeopardize product development and public safety.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Administrative Management and General Management Consulting Services

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Solicitation ID: 75A50123Q00002

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 1235 WESTLAKES DRIVE, BERWYN, PA, 19312

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $88,498,169

Exercised Options: $80,763,392

Current Obligation: $80,763,392

Actual Outlays: $79,645,193

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 47QRAA18D0004

IDV Type: FSS

Timeline